Flörcken A - Search Results

1

Effect of Sunitinib Treatment on Skin Sodium Accumulation in Patients With Renal Cancer: a Pilot Study.

Markó L, Dörr A, Linz P, van den Meiracker AH, Garrelds IM, Kuehne T, Dechend R, Danser AHJ, Flörcken A, Müller DN. Markó L, et al. Among authors: florcken a. Hypertension. 2022 May;79(5):e103-e105. doi: 10.1161/HYPERTENSIONAHA.122.19079. Epub 2022 Feb 22. Hypertension. 2022. PMID: 35189705 No abstract available.

2

Combination therapy with Olaratumab/doxorubicin in advanced or metastatic soft tissue sarcoma -a single-Centre experience.

Striefler JK, Brandes F, Baur A, Pfitzner BM, Kaul D, Rau D, Dörr A, Schmiester M, Koulaxouzidis G, Bullinger L, Märdian S, Flörcken A. Striefler JK, et al. Among authors: florcken a. BMC Cancer. 2020 Jan 29;20(1):68. doi: 10.1186/s12885-020-6551-y. BMC Cancer. 2020. PMID: 31996176 Free PMC article.

3

A Randomized Phase IIa Trial with Temsirolimus versus Sunitinib in Advanced Non-Clear Cell Renal Cell Carcinoma: An Intergroup Study of the CESAR Central European Society for Anticancer Drug Research-EWIV and the Interdisciplinary Working Group on Renal Cell Cancer (IAGN) of the German Cancer Society.

Bergmann L, Grünwald V, Maute L, Grimm MO, Weikert S, Schleicher J, Klotz T, Greiner J, Flörcken A, Hartmann A, Gauler T. Bergmann L, et al. Among authors: florcken a. Oncol Res Treat. 2020;43(7-8):333-339. doi: 10.1159/000508450. Epub 2020 Jun 15. Oncol Res Treat. 2020. PMID: 32541143 Free article. Clinical Trial.

4

Impact of a specialised palliative care intervention in patients with advanced soft tissue sarcoma - a single-centre retrospective analysis.

Brandes F, Striefler JK, Dörr A, Schmiester M, Märdian S, Koulaxouzidis G, Kaul D, Behzadi A, Thuss-Patience P, Ahn J, Pelzer U, Bullinger L, Flörcken A. Brandes F, et al. Among authors: florcken a. BMC Palliat Care. 2021 Jan 14;20(1):16. doi: 10.1186/s12904-020-00702-1. BMC Palliat Care. 2021. PMID: 33446180 Free PMC article.

5

Comorbidities rather than older age define outcome in adult patients with tumors of the Ewing sarcoma family.

Striefler JK, Schmiester M, Brandes F, Dörr A, Pahl S, Kaul D, Rau D, Dobrindt EM, Koulaxouzidis G, Bullinger L, Märdian S, Flörcken A. Striefler JK, et al. Among authors: florcken a. Cancer Med. 2022 Sep;11(17):3213-3225. doi: 10.1002/cam4.4688. Epub 2022 Mar 16. Cancer Med. 2022. PMID: 35297222 Free PMC article.

6

Thrombus or tumor? A case report of a rare sarcoma entity: intimal sarcoma of the pulmonary arteries.

Dörr A, Flörcken A, Bullinger L, Capper D, Deimling AV, Kaul D, Märdian S, Starck C, Horst D, Dragomir MP, Schäfer FM, Jarosch A. Dörr A, et al. Among authors: florcken a. Mol Biol Rep. 2024 Apr 24;51(1):568. doi: 10.1007/s11033-024-09467-9. Mol Biol Rep. 2024. PMID: 38656400 Free PMC article.

7

Long-lasting remission of pulmonary metastases of renal cell cancer under IFN-beta therapy in a patient with multiple sclerosis.

Flörcken A, Denecke T, Kretzschmar A, Gollasch H, Reich G, Westermann J. Flörcken A, et al. Onkologie. 2006 Sep;29(8-9):382-4. doi: 10.1159/000094540. Epub 2006 Sep 5. Onkologie. 2006. PMID: 16974116

8

Can tyrosine kinase inhibitors be discontinued in patients with metastatic renal cell carcinoma and a complete response to treatment? A multicentre, retrospective analysis.

Johannsen M, Flörcken A, Bex A, Roigas J, Cosentino M, Ficarra V, Kloeters C, Rief M, Rogalla P, Miller K, Grünwald V. Johannsen M, et al. Among authors: florcken a. Eur Urol. 2009 Jun;55(6):1430-8. doi: 10.1016/j.eururo.2008.10.021. Epub 2008 Oct 18. Eur Urol. 2009. PMID: 18950936

9

Granulocyte macrophage-colony stimulating factor plus interleukin-2 plus alpha-interferon plus 5-fluorouracil in the treatment of metastatic renal cell cancer: induction of CD80/86+ T cells indicates adverse outcome.

Westermann J, Hecker AC, Flörcken A, Dörken B, Pezzutto A. Westermann J, et al. Among authors: florcken a. J Immunother. 2009 Jul-Aug;32(6):667-75. doi: 10.1097/CJI.0b013e3181a950e5. J Immunother. 2009. PMID: 19483643 Clinical Trial.

10

Severe thrombocytopenia in a patient with metastatic renal cell carcinoma.

Florcken A, Loew A, Koch M, Gebauer B, Dorken B, Riess H. Florcken A, et al. Onkologie. 2009 Nov;32(11):670-2. doi: 10.1159/000242221. Epub 2009 Oct 13. Onkologie. 2009. PMID: 19887872

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

58 results

Search Page